PTCT — PTC Therapeutics, Inc. stock price, charts and financials

QT40PTC Therapeutics, Inc.

PTC Therapeutics, Inc. (NASDAQ: PTCT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
65.37
-2.63-3.87%
OverviewShort InterestFilings
PTCTQT40PTC Therapeutics, Inc.·NASDAQ
65.37-3.87%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 18, 20264Statement of changes in beneficial ownership
Sep 11, 20264Statement of changes in beneficial ownership
Aug 28, 20264Statement of changes in beneficial ownership
Aug 28, 20268-KCurrent report
Aug 21, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 13, 20268-KCurrent report
Aug 06, 20264Statement of changes in beneficial ownership
Jul 30, 20268-KCurrent report
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 202610-QQuarterly report
Jul 30, 20263Initial statement of beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 16, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
#1 / 25 of 458
Page
▼
/ 19